Enzyme, Acyltransferase, Membrane-bound enzyme, Member of the GPAT/AGPAT family
01
Overview
1-acylglycerol-3-phosphate O-acyltransferase 1 (AGPAT1) is a membrane-bound enzyme that resides mainly in the endoplasmic reticulum and catalyzes the acylation of lysophosphatidic acid at the sn-2 position, producing phosphatidic acid, a precursor for key phospholipids and diacylglycerol. AGPAT1 is widely expressed in most tissues and has essential physiological roles in lipid biosynthesis, cellular energy handling, and membrane production. It has documented involvement in metabolic, neurological, and reproductive processes and is linked to disorders such as lipodystrophy and certain cancers. AGPAT1 is being explored as a therapeutic target in diseases associated with disordered lipid metabolism and cell signaling
Drugs targeting AGPAT1 would likely inhibit or modulate the enzyme’s acyltransferase activity, thereby altering the biosynthesis of PA and downstream lipid signaling/metabolism. Modulation may result in changes in cell membrane composition, energy storage, and cellular signaling relevant to proliferation in cancer.
03
Biological functions
Lipid biosynthesis (conversion of LPA to PA)Signal transductionEnergy metabolism (especially in adipose tissue and muscle)Regulation of phospholipid and triacylglyceride (TAG) synthesisCell membrane biosynthesis and remodelingModulation of cellular responses to cytokines
04
Disease associations
Lipodystrophy (distinct from AGPAT2 but involved in adipose tissue metabolism)Cancer (altered metabolism and chemoresistance)Combined oxidative phosphorylation deficiency 8Neurologic disorders (e.g., impact on hippocampal neuron development)Reproductive disorders (sperm development impairment)Other metabolic disturbances
05
Safety considerations
Potential for metabolic disturbances (e.g., energy metabolism impairment, lipodystrophy-like syndromes)Impacts on reproductive function (sperm development and ovulation)Neurological development risk if suppressedTherapeutic targeting may have off-target effects due to broad tissue expression and fundamental roles in membrane synthesis
06
Interacting drugs
No clinically approved direct drugs listed; however, lipid metabolism modulators and investigational compounds targeting AGPAT family members may have relevance
1 more in the full profile.
07
Biomarkers
AGPAT family expression itself is a proposed biomarker in cancer for patient classification, prognosis, and monitoring of metabolic phenotypesAGPAT1 expression in tissues correlates with energy metabolism status and may reflect metabolic homeostasis
Beyond the preview
Go deeper on 1-acylglycerol-3-phosphate O-acyltransferase 1 (AGPAT1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Full profile access
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Full profile access
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Full profile access
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Full profile access
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Full profile access
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Full profile access
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on 1-acylglycerol-3-phosphate O-acyltransferase 1 (AGPAT1).